bleximenib   Click here for help

GtoPdb Ligand ID: 12866

Synonyms: Compound A [WO2022237720] | JNJ-75276617 | JNJ75276617
Compound class: Synthetic organic
Comment: The structure for bleximenib was obtained from proposed INN list 129 (August 2023). This maps to a PubChem CID that describes it as a menin-mixed-lineage leukemia 1 (menin-MLL) inhibitor. The compound is claimed in patent WO2022237720A1 (Janssen, Johnson & Johnson), for potential to treat hematological malignancies (in combination with a BCL-2 inhibitor) [1]. This class of agents disrupts the interaction between MLL oncoproteins (re-arranged MLL fusion proteins that are found in aggressive human acute leukemias) and the tumour suppressor protein menin (MEN1, O00255). Menin is an essential oncogenic co-factor for the leukemogenicity of MLL fusion proteins. The INN was subsequently mapped to the company code JNJ-75276617 [2].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 0
Rotatable bonds 16
Topological polar surface area 85.57
Molecular weight 599.78
XLogP 4.14
No. Lipinski's rules broken 2

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCN(C(C)C)C(=O)C1=CC(=CC=C1OC2=NN=CN=C2N3CCC4(C3)CN(C4)[C@H](CCCN(C)CCOC)C(C)C)F
Isomeric SMILES C(C)N(C(C1=C(C=CC(=C1)F)OC2=C(N=CN=N2)N3CC4(CN(C4)[C@@H](C(C)C)CCCN(C)CCOC)CC3)=O)C(C)C
InChI InChI=1S/C32H50FN7O3/c1-8-40(24(4)5)31(41)26-18-25(33)11-12-28(26)43-30-29(34-22-35-36-30)38-15-13-32(19-38)20-39(21-32)27(23(2)3)10-9-14-37(6)16-17-42-7/h11-12,18,22-24,27H,8-10,13-17,19-21H2,1-7H3/t27-/m1/s1
InChI Key PDUGAXSIWNMIBQ-HHHXNRCGSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
N-ethyl-5-fluoro-2-[[5-[2-[(3R)-6-[2-methoxyethyl(methyl)amino]-2-methylhexan-3-yl]-2,7-diazaspiro[3.4]octan-7-yl]-1,2,4-triazin-6-yl]oxy]-N-propan-2-ylbenzamide
International Nonproprietary Names Click here for help
INN number INN
12759 bleximenib
Synonyms Click here for help
Compound A [WO2022237720] | JNJ-75276617 | JNJ75276617
Database Links Click here for help
CAS Registry No. 2654081-35-1 (source: WHO INN record)
ChEMBL Ligand CHEMBL5314509
GtoPdb PubChem SID 485205987
PubChem CID 156498110
Search Google for chemical match using the InChIKey PDUGAXSIWNMIBQ-HHHXNRCGSA-N
Search Google for chemicals with the same backbone PDUGAXSIWNMIBQ
Search PubMed clinical trials bleximenib
Search PubMed titles bleximenib
Search PubMed titles/abstracts bleximenib
UniChem Compound Search for chemical match using the InChIKey PDUGAXSIWNMIBQ-HHHXNRCGSA-N
UniChem Connectivity Search for chemical match using the InChIKey PDUGAXSIWNMIBQ-HHHXNRCGSA-N

Product suppliers

View disclaimer

MedChemExpress
Bleximenib (links to external site)
Cat. No. HY-148669